Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease.
Zhang W, Smith N, Zhou Y, McGee CM, Bartoli M, Fu S, Chen J, Domena JB, Joji A, Burr H, Lv G, Cilingir EK, Bedendo S, Claure ML, Tagliaferro A, Eliezer D, Veliz EA, Zhang F, Wang C, Leblanc RM. Zhang W, et al. Among authors: joji a. Acta Biomater. 2024 Jul 15;183:341-355. doi: 10.1016/j.actbio.2024.06.001. Epub 2024 Jun 5. Acta Biomater. 2024. PMID: 38849023
Amplifying gene expression with RNA-targeted therapeutics.
Khorkova O, Stahl J, Joji A, Volmar CH, Wahlestedt C. Khorkova O, et al. Among authors: joji a. Nat Rev Drug Discov. 2023 Jul;22(7):539-561. doi: 10.1038/s41573-023-00704-7. Epub 2023 May 30. Nat Rev Drug Discov. 2023. PMID: 37253858 Free PMC article. Review.
Natural antisense transcripts as drug targets.
Khorkova O, Stahl J, Joji A, Volmar CH, Zeier Z, Wahlestedt C. Khorkova O, et al. Among authors: joji a. Front Mol Biosci. 2022 Sep 27;9:978375. doi: 10.3389/fmolb.2022.978375. eCollection 2022. Front Mol Biosci. 2022. PMID: 36250017 Free PMC article. Review.
Erratum: First-in-class pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights.
Ramesh D, Sarkar D, Joji A, Singh M, Mohanty AK, Vijayakumar BG, Chatterjee M, Sriram D, Muthuvel SK, Kannan T. Ramesh D, et al. Among authors: joji a. Arch Pharm (Weinheim). 2022 Apr;355(4):e2270007. doi: 10.1002/ardp.202270007. Epub 2022 Mar 1. Arch Pharm (Weinheim). 2022. PMID: 35229349 No abstract available.
A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH, Gupta R, Adulkar N, Nair AG, Bradoo RA, Hegde R, Singh U, Tadepalli S, Mukherjee B, Kamal S, Alam MS, Rao R, Ananthakrishna S, Backiavathy V, Murthy AK, D'Cunha L, Dudeja G, Joji A, Kiran A, Koka K, Goswami Mukhopadhyay M, Nisar SP, Rao PR, Shinde CA. Vasanthapuram VH, et al. Among authors: joji a. Orbit. 2023 Feb;42(1):30-41. doi: 10.1080/01676830.2021.2020851. Epub 2022 Feb 22. Orbit. 2023. PMID: 35192435
12 results